1,007 results on '"Xu, Jingyu"'
Search Results
102. Research progress on the roles of dopamine and dopamine receptors in digestive system diseases
103. Supplementary Figure S2 from Monitoring Minimal Residual Disease in Patients with Multiple Myeloma by Targeted Tracking Serum M-Protein Using Mass Spectrometry (EasyM)
104. Supplementary Methods S1 from Monitoring Minimal Residual Disease in Patients with Multiple Myeloma by Targeted Tracking Serum M-Protein Using Mass Spectrometry (EasyM)
105. Supplementary Table S3 from Monitoring Minimal Residual Disease in Patients with Multiple Myeloma by Targeted Tracking Serum M-Protein Using Mass Spectrometry (EasyM)
106. Data from Monitoring Minimal Residual Disease in Patients with Multiple Myeloma by Targeted Tracking Serum M-Protein Using Mass Spectrometry (EasyM)
107. Research on multi-objective parameter optimization of split flow dual flash thermodynamic cycle
108. Study on Breakage Mechanism in the Swirl Generating Stage of an Oil-Water Separator for Marine Oil Extraction and Its Verification
109. Preparation of butadiene-bridged polymethylsiloxane (BBPMS)/ethyl cellulose (EC) hybrid membranes for gas separation
110. The Integration of Large-Scale Language Models Into Intelligent Adjudication: Justification Rules and Implementation Pathways
111. Design and performance study of gas–liquid separation–mixing device for electric submersible pump in high-gas-content oil wells.
112. Liquid–solid two-phase flow and separation behavior in a novel cyclone separator.
113. Experimental and numerical study of separation characteristics in gas-liquid cylindrical cyclone
114. Imidazolium-based ionic porous hybrid polymers with POSS-derived silanols for efficient heterogeneous catalytic CO2 conversion under mild conditions
115. Oral microbiota–host interaction: the chief culprit of alveolar bone resorption
116. MXene: A wonderful nanomaterial in antibacterial
117. Development and validation of an individualized and weighted Myeloma Prognostic Score System (MPSS) in patients with newly diagnosed multiple myeloma
118. MAF translocation remains a strong prognostic factor despite concurrent chromosomal abnormalities
119. Strain-Stiffening Transparent Hydrogel: Integrating Mechanical Adaptability and Solar Polarization Positioning
120. Monitoring Minimal Residual Disease in Patients with Multiple Myeloma by Targeted Tracking Serum M-Protein Using Mass Spectrometry (EasyM)
121. A rational and efficient local stress recovery method for composite laminates
122. Genome-Wide Identification and Functional Analyses of the 5-O-Glucosyltransferase (5gt) Family Reveal its Potential Roles in Anthocyanidin Diglucosides Synthesis of Grape Skins with Vitis Amurensis Pedigree
123. The Immune Depth Presentation Convolutional Neural Network Used for Oil and Gas Pipeline Fault Diagnosis
124. Longitudinal genetically detectable minimal residual disease by fluorescence in situ hybridization confers a poor prognosis in myeloma
125. Achieving prominent high-temperature mechanical properties in a dual-phase high-entropy alloy: a synergy of deformation-induced twinning and martensite transformation
126. An investigation of the cavitation and vibration phenomena in a cylindrical cyclone
127. A novel maize F-bZIP member, ZmbZIP76, functions as a positive regulator in ABA-mediated abiotic stress tolerance by binding to ACGT-containing elements
128. Estrogen Regulates Duodenal Calcium Absorption Through Differential Role of Estrogen Receptor on Calcium Transport Proteins
129. Association of three micro-RNA gene polymorphisms with the risk of cervical cancer: a meta-analysis and systematic review
130. Ultra-stable K metal anode enabled by oxygen-rich carbon cloth
131. Depolymerization of corn cobs using the CO2/lithium bromide trihydrate system for low molecular weight lignin with high antioxidant activity.
132. Synthesis of rhodium catalyst [Rh(cod)(TTT)2] with amino group ligand and its catalytic performance for phenylacetylene polymerization.
133. Development and Evaluation of Intelligent Medical Decision Support Systems
134. Automated Scoring of Clinical Patient Notes Using Advanced NLP and Pseudo Labeling
135. Based on TPUGRAPHS Predicting Model Runtimes Using Graph Neural Networks
136. Early relapse within 18 months (ER18) is a powerful dynamic predictor for prognosis and could revise static risk distribution in multiple myeloma
137. Immunotherapy for multiple myeloma: new chances and hope
138. Impact of Informatization and Corporate ESG Performance: A Quasi-Natural Experiment Based on Smart City Pilots
139. Clinical Benefit of Autologous Stem Cell Transplantation for Patients with Multiple Myeloma Achieving Undetectable Minimal Residual Disease after Induction Treatment
140. FIGURE 1 from Clinical Benefit of Autologous Stem Cell Transplantation for Patients with Multiple Myeloma Achieving Undetectable Minimal Residual Disease after Induction Treatment
141. TABLE 1 from Clinical Benefit of Autologous Stem Cell Transplantation for Patients with Multiple Myeloma Achieving Undetectable Minimal Residual Disease after Induction Treatment
142. Table S2 from Clinical Benefit of Autologous Stem Cell Transplantation for Patients with Multiple Myeloma Achieving Undetectable Minimal Residual Disease after Induction Treatment
143. TABLE 2 from Clinical Benefit of Autologous Stem Cell Transplantation for Patients with Multiple Myeloma Achieving Undetectable Minimal Residual Disease after Induction Treatment
144. Figure S1 from Clinical Benefit of Autologous Stem Cell Transplantation for Patients with Multiple Myeloma Achieving Undetectable Minimal Residual Disease after Induction Treatment
145. FIGURE 4 from Clinical Benefit of Autologous Stem Cell Transplantation for Patients with Multiple Myeloma Achieving Undetectable Minimal Residual Disease after Induction Treatment
146. FIGURE 2 from Clinical Benefit of Autologous Stem Cell Transplantation for Patients with Multiple Myeloma Achieving Undetectable Minimal Residual Disease after Induction Treatment
147. FIGURE 3 from Clinical Benefit of Autologous Stem Cell Transplantation for Patients with Multiple Myeloma Achieving Undetectable Minimal Residual Disease after Induction Treatment
148. Data from Clinical Benefit of Autologous Stem Cell Transplantation for Patients with Multiple Myeloma Achieving Undetectable Minimal Residual Disease after Induction Treatment
149. P-339 Longitudinal genetically detectable minimal residual disease by interphase fluorescence in situ hybridization confers a poor prognosis in multiple myeloma
150. P-327 Hyposecretory progression pattern indicates inferior survival of multiple myeloma
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.